Overview

A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart Rate

Status:
COMPLETED
Trial end date:
2025-06-12
Target enrollment:
Participant gender:
Summary
This study will evaluate the impact of rapid acceleration in the heart rate on the QT prolongation of quizartinib.
Phase:
PHASE1
Details
Lead Sponsor:
Daiichi Sankyo
Treatments:
quizartinib